Does FEDRATINIB Cause Second primary malignancy? 6 Reports in FDA Database

Q: Does FEDRATINIB cause Second primary malignancy?

6 reports of Second primary malignancy have been filed with the FDA for FEDRATINIB, representing 0.4% of all FEDRATINIB adverse event reports.

Q: How dangerous is Second primary malignancy from FEDRATINIB?

Of 6 reports, 5 (83.3%) resulted in death and 0 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Second primary malignancy have been filed in association with FEDRATINIB (Inrebic). This represents 0.4% of all adverse event reports for FEDRATINIB.

Reports of Second primary malignancy with FEDRATINIB

0.4%

of all FEDRATINIB reports

Deaths

Hospitalizations

How Dangerous Is Second primary malignancy From FEDRATINIB?

Of the 6 reports, 5 (83.3%) resulted in death.

Is Second primary malignancy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FEDRATINIB. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does FEDRATINIB Cause?

Diarrhoea (143) Death (138) Nausea (114) Fatigue (105) Vomiting (74) Constipation (59) Platelet count decreased (48) Asthenia (47) Haemoglobin decreased (46) Full blood count decreased (45)

What Other Drugs Cause Second primary malignancy?

CYCLOPHOSPHAMIDE (1,247) DOXORUBICIN (1,151) VINCRISTINE (908) IMATINIB (763) PALBOCICLIB (658) RITUXIMAB (646) RUXOLITINIB (611) ETOPOSIDE (573) PREDNISONE (517) OCTREOTIDE (496)

Which FEDRATINIB Alternatives Have Lower Second primary malignancy Risk?

FEDRATINIB vs FELBAMATE FEDRATINIB vs FELIS CATUS HAIR FEDRATINIB vs FELODIPINE FEDRATINIB vs FENFLURAMINE FEDRATINIB vs FENOFIBRATE

FEDRATINIB Full Profile All Second primary malignancy Reports All Drugs Causing Second primary malignancy FEDRATINIB Demographics